These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 23035074

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fingolimod and multiple sclerosis: four cautionary tales.
    Bourdette D, Gilden D.
    Neurology; 2012 Nov 06; 79(19):1942-3. PubMed ID: 23035058
    [No Abstract] [Full Text] [Related]

  • 3. Rebound of disease activity during pregnancy after withdrawal of fingolimod.
    Sempere AP, Berenguer-Ruiz L, Feliu-Rey E.
    Eur J Neurol; 2013 Aug 06; 20(8):e109-10. PubMed ID: 23829238
    [No Abstract] [Full Text] [Related]

  • 4. Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report.
    Conzett KB, Kolm I, Jelcic I, Kamarachev J, Dummer R, Braun R, French LE, Linnebank M, Hofbauer GF.
    Arch Dermatol; 2011 Aug 06; 147(8):991-2. PubMed ID: 21844470
    [No Abstract] [Full Text] [Related]

  • 5. Fingolimod for multiple sclerosis.
    Pelletier D, Hafler DA.
    N Engl J Med; 2012 Jan 26; 366(4):339-47. PubMed ID: 22276823
    [No Abstract] [Full Text] [Related]

  • 6. T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
    Ricklin ME, Lorscheider J, Waschbisch A, Paroz C, Mehta SK, Pierson DL, Kuhle J, Fischer-Barnicol B, Sprenger T, Lindberg RL, Kappos L, Derfuss T.
    Neurology; 2013 Jul 09; 81(2):174-81. PubMed ID: 23700335
    [Abstract] [Full Text] [Related]

  • 7. Fingolimod: cardiovascular deaths.
    Prescrire Int; 2012 Apr 09; 21(126):99. PubMed ID: 22515137
    [No Abstract] [Full Text] [Related]

  • 8. [Fingolimod treatment in multiple sclerosis].
    Tanaka M.
    Nihon Rinsho; 2014 Nov 09; 72(11):2010-4. PubMed ID: 25518386
    [Abstract] [Full Text] [Related]

  • 9. Severe multiple sclerosis relapse under fingolimod therapy: incident or coincidence?
    Castrop F, Kowarik MC, Albrecht H, Krause M, Haslinger B, Zimmer C, Berthele A, Hemmer B.
    Neurology; 2012 Mar 20; 78(12):928-30. PubMed ID: 22402856
    [No Abstract] [Full Text] [Related]

  • 10. Cystoid macular edema associated with fingolimod use for multiple sclerosis.
    Afshar AR, Fernandes JK, Patel RD, Ksiazek SM, Sheth VS, Reder AT, Hariprasad SM.
    JAMA Ophthalmol; 2013 Jan 20; 131(1):103-7. PubMed ID: 23307220
    [No Abstract] [Full Text] [Related]

  • 11. Oral fingolimod (gilenya) for multiple sclerosis.
    Med Lett Drugs Ther; 2010 Dec 29; 52(1353-1354):98-9. PubMed ID: 21344782
    [No Abstract] [Full Text] [Related]

  • 12. Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient.
    Lysandropoulos AP, Benghiat F.
    Mult Scler; 2013 Oct 29; 19(11):1551-2. PubMed ID: 23817558
    [No Abstract] [Full Text] [Related]

  • 13. Branch retinal vein occlusion during fingolimod treatment in a patient with multiple sclerosis.
    Gallego-Pinazo R, España-Gregori E, Casanova B, Pardo-López D, Díaz-Llopis M.
    J Neuroophthalmol; 2011 Sep 29; 31(3):292-3. PubMed ID: 21826025
    [No Abstract] [Full Text] [Related]

  • 14. Delayed fingolimod-associated asystole.
    Espinosa PS, Berger JR.
    Mult Scler; 2011 Nov 29; 17(11):1387-9. PubMed ID: 21652609
    [Abstract] [Full Text] [Related]

  • 15. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
    Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L, TRANSFORMS Study Group.
    N Engl J Med; 2010 Feb 04; 362(5):402-15. PubMed ID: 20089954
    [Abstract] [Full Text] [Related]

  • 16. Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
    Leypoldt F, Münchau A, Moeller F, Bester M, Gerloff C, Heesen C.
    Neurology; 2009 Mar 17; 72(11):1022-4. PubMed ID: 19289744
    [No Abstract] [Full Text] [Related]

  • 17. Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment.
    Rolf L, Muris AH, Damoiseaux J, van Daele M, Hupperts R.
    Neurology; 2014 Mar 18; 82(11):1008-9. PubMed ID: 24523479
    [No Abstract] [Full Text] [Related]

  • 18. [New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimod].
    Komoly S.
    Ideggyogy Sz; 2012 Nov 30; 65(11-12):421-2. PubMed ID: 23289178
    [No Abstract] [Full Text] [Related]

  • 19. Primary varicella zoster infection associated with fingolimod treatment.
    Uccelli A, Ginocchio F, Mancardi GL, Bassetti M.
    Neurology; 2011 Mar 15; 76(11):1023-4. PubMed ID: 21403115
    [No Abstract] [Full Text] [Related]

  • 20. Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient.
    Piscolla E, Hakiki B, Pastò L, Razzolini L, Portaccio E, Amato MP.
    J Neurol; 2013 Jun 15; 260(6):1675-7. PubMed ID: 23645219
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.